-
- 抗原 See all CD16 抗体
- CD16
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CD16 antibody is un-conjugated
-
应用范围
- Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 特异性
- This antibody reacts with a 50-70 kD glycoprotein (CD16) that is expressed on NK cells, granulocytes, active macrophages, and a small subset of T-cells.
- 纯化方法
- Purified.
- 免疫原
- Human PBLs for a NK-leukemia patient.
- 克隆位点
- B338 (HuNK2)
- 亚型
- IgG2a
- Top Product
- Discover our top product CD16 Primary Antibody
-
-
- 应用备注
-
Immunofluorescence: 5-20 ug/mL.
Flow cytometry: 1-5 ug/10^6 cells.
Immunohistochemistry: 5-20 ug/mL on frozen sections using avidin-biotin system.
This product was not quality controlled in flow cytometry.
Staining Procedure: This antibody can be used on frozen cryostat sections. - 说明
-
Recommended Positive Control: Tonsil and Lymph Node
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.4 mg/ml.
- 缓冲液
- 50 mM Sodium Borate, 150 mM Sodium Chloride, 20% Glycerol, pH 8.0
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
-
-
Community-based health care 10 years post Alma Ata." in: Social science & medicine (1982), Vol. 28, Issue 10, pp. 1005-6, (1989) (PubMed).
: "
-
Community-based health care 10 years post Alma Ata." in: Social science & medicine (1982), Vol. 28, Issue 10, pp. 1005-6, (1989) (PubMed).
-
- 抗原
- CD16
- Abstract
- CD16 产品
- 别名
- Fcgr3 antibody, Fcgr3a antibody, CD16 antibody, FCGR3 antibody, FCGR3@ antibody, CD16b antibody, FCG3 antibody, FCR-10 antibody, FCRIII antibody, FCRIIIb antibody, FcRIII antibody, Fc fragment of IgG, low affinity IIa, receptor antibody, Fc fragment of IgG, low affinity IIIa, receptor (CD16a) antibody, Fc fragment of IgG receptor IIIb antibody, Fc fragment of IgG receptor IIIa antibody, Fc receptor, IgG, low affinity III antibody, Fc-gamma RIII antibody, Fcgr2a antibody, FCGR3A antibody, FCGR3B antibody, Fcgr3 antibody, FCGR3 antibody
- 基因ID
- 2214
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-